Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kura Oncology, Inc.(KURA) | 1,849,947 | 1,849,947 | 0 | 39,459 | 38,090 | 25.59% | -1,369 |
| Syndax Pharmaceuticals, Inc.(SNDX) | 875,000 | 875,000 | 0 | 20,825 | 17,964 | 12.07% | -2,861 |
| Lyell Immunopharma, Inc.(LYEL) | 8,325,000 | 8,325,000 | 0 | 18,565 | 12,071 | 8.11% | -6,493 |
| Pharvaris N.V. COM | 4,038,842 | 4,293,854 | +255,012 | 93,338 | 80,724 | 54.23% | -12,613 |
| Kinnate Biopharma Inc. | 9,671,643 | 0 | -9,671,643 | 25,727 | 0 | — | -25,727 |